GLP toxicology studies ongoing for CMP-002, with initiation of global Phase 1/2 clinical trial in SYNGAP1 patients expected as early as 2H 2026 Entered strategic collaboration with GSK to advance RNA- ...
Annuities get a bad rap, often labelled “too expensive”, “crammed with hidden fees,” or just “not a good investment.” Here’s the thing, though. All this criticism often lacks specific financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results